# Safety and Tolerability of Oral Proglumide for NASH

> **NCT04152473** · PHASE1 · COMPLETED · sponsor: **Georgetown University** · enrollment: 18 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Proglumide

## Key facts

- **NCT ID:** NCT04152473
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-13
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-09-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04152473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04152473, "Safety and Tolerability of Oral Proglumide for NASH". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT04152473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*